Eleonora Diella
Bosisio Parini, Italy
NCT Number: NCT04256681
The Self-Notion and Perception (SNAP) questionnaire developed at IRCCS E.Medea by Eleonora Diella and Roberta Morganti, arises from the need to quantify the subjective perception of the patient suffering from HSP of the typical symptoms of pathology, such as spasticity, weakness, changes in balance, resistance in walking, pain and fatigue. The purpose of this study is to validate this instrument and test its reliability, looking for correlations with the measurement scales used in the literature for the evaluation of the patient with HSP. The most used for this population are the Spastic Paraplegia Rating Scale (SPRS) and the Six-Minute Walk Test (6MWT) which assess the severity of the disease and the level of endurance (8-9) respectively.
Looking for future studies?
Notify Me9 year and older
All sexes
Interventional
Not applicable
Bosisio Parini, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The SNAP questionnaire will be administered 2 times in 2 consecutive days to evaluate its reliability. The questionnaire will be self-filled by the patient. Then the SPRS scale and, where possible, the 6MWT will be administered.
Time frame: 2 days
the Spastic Paraplegia Rating Scale (SPRS) and the Six-Minute Walk Test (6MWT) which assess the severity of the disease and the level of endurance respectively.
IRCCS Eugenio Medea
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04768166
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Pisa, PI, Italy
View Trial DetailsNCT00677768
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT06573866
Ataxia, Basal Ganglia Diseases
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT07090057
Brain Damage, Chronic, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details